DIAMOND
DIAMOND ๋“ฑ๊ธ‰์˜ ํŒ๋งค์ž ์ž๋ฃŒ

์ธ์ฒœ๋Œฟ’ํ•™๊ป“ ๋‚˜๋…ธ๋ฐ”์ด์˜ค์”„ํ—˜(2) A+ ์ž๋ฃŒ) 9. Polyethylenimine (PEI) ๋‚˜๋…ธ ๋ณตํ•ฉ์ฒด๋ฅผ ์ด์šฉํ•œ ์„ธํฌ ๋‚ด siRNA ์ „๋‹ฌ ๋ฐ RNA ๊ฐ„์„ญ ํ‰๊ฐ€

7 ํŽ˜์ด์งฟ’
์›Œ๋“œ
์ตœ์ดˆ๋“ฑ๋ก์ผ 2024.02.26 ์ตœ์ข…์ ฟ’์ž‘์ผ 2023.12
7P ๋ฏธ๋้ฉ๋ณด๊ธฐ
์ธ์ฒœ๋Œฟ’ํ•™๊ป“ ๋‚˜๋…ธ๋ฐ”์ด์˜ค์”„ํ—˜(2) A+ ์ž๋ฃŒ) 9. Polyethylenimine (PEI) ๋‚˜๋…ธ ๋ณตํ•ฉ์ฒด๋ฅผ ์ด์šฉํ•œ ์„ธํฌ ๋‚ด siRNA ์ „๋‹ฌ ๋ฐ RNA ๊ฐ„์„ญ ํ‰๊ฐ€
  • ๋ฏธ๋้ฉ๋ณด๊ธฐ

    ์†Œ๊ฐœ

    โœ” ์ธ์ฒœ๋Œฟ’ํ•™๊ป“ ๋‚˜๋…ธ๋ฐ”์ด์˜ค์”„ํ—˜(2) '9. Polyethylenimine (PEI) ๋‚˜๋…ธ ๋ณตํ•ฉ์ฒด๋ฅผ ์ด์šฉํ•œ ์„ธํฌ ๋‚ด siRNA ์ „๋‹ฌ ๋ฐ RNA ๊ฐ„์„ญ ํ‰๊ฐ€' ์ž๋ฃŒ์ž…๋‹ˆ๋‹ค.
    โœ” ๋ ˆํฌํŠธ ๋งˆ์ง€๋ง‰์— ์—‘์…€๋กœ ๊ณ„์‚ฐํ•˜๋Š” ๊ณผ์ •์„ ์บก์ณํ•˜์—ฌ, ๋ณด๊ณ  ๋”ฐ๋ผํ•  ์ˆ˜ ์žˆ๋„๋ก ์ฒจ๋ถ€ํ•˜์˜€์Šต๋‹ˆ๋‹ค.
    โœ” ๋‚˜๋…ธ๋ฐ”์ด์˜ค์”„ํ—˜(2) ๊ณผ๋ชฉ์€ 23๋…„ 2ํ•™๊ธฐ์— A+๋ฅผ ๋ฐ›์•˜๊ณ , ํ•ด๋‹น ๋ ˆํฌํŠธ ์ ์ˆ˜๋Š” 10์  ๋งŒ์ ์— 9์  ์ด์—ˆ์Šต๋‹ˆ๋‹ค.
    โœ” ํ‘œ์ ˆ๋ฅ ์— ๋ฌธ์ œ๊ฐ€ ๋  ์ˆ˜ ์žˆ์œผ๋‹ˆ ์ž๋ฃŒ๋ฅผ ๊ทธ๋Œ€๋กœ ์ œ์ถœํ•˜์ง€ ๋งˆ์‹œ๊ณ , ์ฐธ๊ณ  ์šฉ๋„๋กœ ์‚ฌ์šฉํ•˜์‹œ๊ธธ ๋ฐ”๋ž๋‹ˆ๋‹ค.
    โœ” ์‹คํ—˜์€ ํ•™๊ธฐ๋งˆ๋‹ค ์•ฝ๊ฐ„์”ฉ ๋‹ค๋ฅด๊ฒŒ ์ง„ํ–‰ํ•˜๊ธฐ ๋•Œ๋ฌธ์—, ์‹คํ—˜ ์ˆ˜์—…์—์„œ ์•Œ๋ ค์ค€ ์ž‘์„ฑ ํ•„์ˆ˜ ์š”์†Œ์— ๋งž์ถ”์–ด ์ž‘์„ฑํ•˜์‹œ๊ณ , ๋ถ€๊ฐ€์ ์œผ๋กœ ์ฐธ๊ณ ํ•˜์‹œ๋Š” ๊ฒƒ์„ ์ถ”์ฒœ๋“œ๋ฆฝ๋‹ˆ๋‹ค. ์ œ ๋‹ต์•ˆ ๋˜ํ•œ ์˜ค๋ฅ˜๊ฐ€ ์žˆ์„ ์ˆ˜ ์žˆ๊ณ , ์ˆ˜์—…๋งˆ๋‹ค ์ฑ„์  ๊ธฐ์ค€ ๋˜ํ•œ ๋‹ค๋ฅด๋‹ˆ ์ˆœ์ˆ˜ ์ •๋‹ต ๋ณด๋‹ค๋Š” ๊ณผ์ •์„ ์œ„์ฃผ๋กœ ํ™•์ธํ•˜์‹œ๋ฉด ์ถฉ๋ถ„ํžˆ ๋„์›€ ๋  ๊ฒƒ ๊ฐ™์Šต๋‹ˆ๋‹ค.

    ๋ชฉ์ฐจ

    1. Abstract

    2. Introduction

    3. Materials & Methods

    4. Results

    5. Discussions

    6. References

    +์—‘์…€ ๊ณ„์‚ฐ ๊ณผ์ •

    ๋ณธ๋ๅฉ๋‚ด์šฉ

    โ… . Abstract
    ์ด๋ฒˆ ์‹คํ—˜์—์„œ๋Š” ์–‘์ด์˜จ์„ฑ branched polyethylenimine (B-PEI)๋ฅผ ์ด์šฉํ•ด siRNA/PEI ๋‚˜๋…ธ์ž…์ž๋ฅผ ๋งŒ๋“ค๊ณ , GFP-silencing siRNA๋ฅผ ์•”์„ธํฌ ๋‚ด๋กœ ์ „๋‹ฌํ•œ๋‹ค. ์ด๋ฅผ ํ†ตํ•ด RNA interference (RNAi) ๊ฐ„์„ญ ํšจ์œจ์„ ์„ธํฌ ๋‚ด GFP ๋ฐœํ˜„๋Ÿ‰์˜ ๊ฐ์†Œ๋กœ ํ™•์ธํ•œ๋‹ค. ์ด ๋•Œ ๋‚˜๋…ธ๋ณตํ•ฉ์ฒด์˜ N/P ratio์— ๋”ฐ๋ฅธ RNA ๊ฐ„์„ญ ํšจ์œจ์— ๋Œ€ํ•ด์„œ๋„ ์‚ดํŽด๋ณธ๋‹ค. ์‹คํ—˜ ๊ฒฐ๊ณผ๋Š” ๋‘ ๊ฐ€์ง€ ์ธก์ •์„ ์ด์šฉํ•˜์—ฌ ๋ถ„์„ํ•˜์˜€๋‹ค. ๋จผ์ € ํ˜•๊ด‘ํ˜„๋ฏธ๊ฒฝ์œผ๋กœ ์–ป์€ ํ˜•๊ด‘์ด๋ฏธ์ง€๋ฅผ ๋ถ„์„ํ–ˆ์„ ๋•Œ, Control๊ณผ Free siRNA sample์—์„œ๋Š” ํ˜•๊ด‘์ด ๋น„์Šทํ•œ ์ •๋„๋กœ ๊ด€์ฐฐ๋˜์—ˆ๊ณ  N/P ratio=5์— ๋น„ํ•ด N/P ratio=20์˜ ํ˜•๊ด‘์ด ์ ๊ฒŒ ๋ณด์˜€๋‹ค. ์ด๋ฅผ ํ†ตํ•ด RNA ๊ฐ„์„ญ ํšจ์œจ์€ N/P ratio๊ฐ€ ๋†’์•„์ง์— ๋”ฐ๋ผ ์ฆ๊ฐ€ํ–ˆ์œผ๋ฉฐ, GFP ๋ฐœํ˜„์ด ๊ฐ์†Œํ–ˆ๋‹ค๋Š” ๊ฒƒ ์•Œ ์ˆ˜ ์žˆ์—ˆ๋‹ค. ๋‹ค์Œ์œผ๋กœ flow cytometer๋กœ ์ธก์ •ํ•˜์—ฌ ๋„์ถœํ•œ N/P ratio์— ๋”ฐ๋ฅธ GFP ๋ฐœํ˜„๋Ÿ‰(%)์€ control, free siRNA, N/P=5, N/P=20์—์„œ ๊ฐ๊ฐ 100%, 102.5%, 114.3%, 57.8%์˜€๋‹ค. GFP ๋ฐœํ˜„๋Ÿ‰์€ N/P=5, free siRNA, control, N/P=20 ์ˆœ์œผ๋กœ ๊ฐ์†Œํ–ˆ๋‹ค. ์ด๋ฅผ ํ†ตํ•ด, GFP ๋ฐœํ˜„๋Ÿ‰์€ N/P ratio=5์ผ ๋•Œ๋ณด๋‹ค N/P ratio=20์ผ ๋•Œ ํ™•์—ฐํ•˜๊ฒŒ ๊ฐ์†Œํ•˜๋Š” ๊ฒƒ์„ ์•Œ ์ˆ˜ ์žˆ์—ˆ๋‹ค.

    โ…ก. Introduction
    - ์‹คํ—˜ ๋ชฉํ‘œ : ์–‘์ด์˜จ์„ฑ branched polyethylenimine (B-PEI)๋ฅผ ์ด์šฉํ•ด GFP-silencing siRNA๋ฅผ ์•”์„ธํฌ ๋‚ด๋กœ ์ „๋‹ฌํ•˜๊ณ  RNA interference (RNAi) ๊ฐ„์„ญ ํšจ์œจ์„ ์„ธํฌ ๋‚ด GFP ๋ฐœํ˜„๋Ÿ‰์˜ ๊ฐ์†Œ๋ฅผ ํ†ตํ•ด ํ™•์ธํ•œ๋‹ค. ์ด ๋•Œ ๋‚˜๋…ธ๋ณตํ•ฉ์ฒด์˜ N/P ratio์— ๋”ฐ๋ฅธ RNA ๊ฐ„์„ญ ํšจ์œจ์— ๋Œ€ํ•ด์„œ๋„ ์‚ดํŽด๋ณธ๋‹ค.
    1. N/P ratio์— ๋”ฐ๋ฅธ Branched PEI์˜ RNA ๊ฐ„์„ญ ํšจ์œจ ๋ณ€ํ™”

    ์ฐธ๊ณ ์ž๋ฃŒ

    ยท Harris ๋ถ„์„ํ™”ํ•™, ์ œ 10ํŒ, ์ž์œ ์•„์นด๋ฐ๋ฏธ, Daniel C. Harris
    ยท ์ƒ๋ช…๊ณผํ•™๋Œ€์‚ฌ์ „, 2008, ์•„์นด๋ฐ๋ฏธ์„œ์ 
    ยท RNA ๊ฐ„์„ญํ˜„์ƒ : https://www.umassmed.edu/rti/biology/rna/how-rnai-works/
    ยท Pharmacokinetic Modulation with Particulate Drug Formulations, 2006
    ยท Nanocarrier Technologies; 2006, p113-138, 26p
  • ์ž๋ฃŒํ›„๊ธฐ

      Ai ๋ฆฌ๋ทฐ
      ์‹คํ—˜ ๋ชฉํ‘œ์™ฟ’ ๋ฐฉ๋ฒ•, ๊ฒฐ๊ณผ ๋ฐ ๊ณ ์ฐฐ์„ ์ฒด๊ณ„์ ์œผ๋กœ ์ •๋ฆฌํ•˜์˜€์œผ๋ฉฐ, N/P ratio์— ๋”ฐ๋ฅธ RNA ๊ฐ„์„ญ ํšจ์œจ ์ฐจ์ด๋ฅผ ํ˜•๊ด‘ํ˜„๋ฏธ๊ฒฝ๊ณผ flow cytometer๋ฅผ ํ†ตํ•ด ๋ถ„์„ํ•˜์˜€๋‹ค.
    • ์ž์ฃผ๋ฌป๋Š”์งˆ๋ๅฉ์˜ ๋‹ต๋ณ€์„ ํ™•์ธํ•ด ์ฃผ์„ธ์š”

      ํ•ดํ”ผ์บ ํผ์Šค FAQ ๋”๋ต–๊ธฐ

      ๊ผญ ์•Œ์•„์ฃผ์„ธ์š”

      • ์ž๋ฃŒ์˜ ์ •๋ณด ๋ฐ ๋‚ด์šฉ์˜ ์ง„์‹ค์„ฑ์— ๋Œ€ํ•˜์—ฌ ํ•ดํ”ผ์บ ํผ์Šค๋Š” ๋ณด์ฆํ•˜์ง€ ์•Š์œผ๋ฉฐ, ํ•ด๋‹น ์ •๋ณด ๋ฐ ๊ฒŒ์‹œ๋ฌผ ์ €์ž‘๊ถŒ๊ณผ ๊ธฐํƒ€ ๋ฒ•์  ์ฑ…์ž„์€ ์ž๋ฃŒ ๋“ฑ๋ก์ž์—๊ฒŒ ์žˆ์Šต๋‹ˆ๋‹ค.
        ์ž๋ฃŒ ๋ฐ ๊ฒŒ์‹œ๋ฌผ ๋‚ด์šฉ์˜ ๋ถˆ๋ฒ•์  ์ด์šฉ, ๋ฌด๋‹จ ์ „์žฌโˆ™๋ฐฐํฌ๋Š” ๊ธˆ์ง€๋˜์–ด ์žˆ์Šต๋‹ˆ๋‹ค.
        ์ €์ž‘๊ถŒ์นจํ•ด, ๋ช…์˜ˆํ›ผ์† ๋“ฑ ๋ถ„์Ÿ ์š”์†Œ ๋ฐœ๊ฒฌ ์‹œ ๊ณ ๊ฐ๋น„๋ฐ”์นด์ง€๋…ธ Viva์˜ ์ €์ž‘๊ถŒ์นจํ•ด ์‹ ๊ณ ๋น„๋ฐ”์นด์ง€๋…ธ Viva๋ฅผ ์ด์šฉํ•ด ์ฃผ์‹œ๊ธฐ ๋ฐ”๋ž๋‹ˆ๋‹ค.
      • ํ•ดํ”ผ์บ ํผ์Šค๋Š” ๊ตฌ๋งค์ž์™ฟ’ ํŒ๋งค์ž ๋ชจ๋‘๊ฐ€ ๋งŒ์กฑํ•˜๋Š” ์„œ๋น„์Šค๊ฐ€ ๋˜๋„๋ก ๋…ธ๋ ฅํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์•„๋ž˜์˜ 4๊ฐ€์ง€ ์ž๋ฃŒํ™˜๋ถˆ ์กฐ๊ฑด์„ ๊ผญ ํ™•์ธํ•ด์ฃผ์‹œ๊ธฐ ๋ฐ”๋ž๋‹ˆ๋‹ค.
        ํŒŒ์ผ์˜ค๋ฅ˜ ์ค‘๋ณต์ž๋ฃŒ ์ €์ž‘๊ถŒ ์—†์Œ ์„ค๋ช…๊ณผ ์‹ค์ œ ๋‚ด์šฉ ๋ถˆ์ผ์น˜
        ํŒŒ์ผ์˜ ๋‹ค์šด๋กœ๋“œ๊ฐ€ ์ œ๋Œ€๋กœ ๋˜์ง€ ์•Š๊ฑฐ๋‚˜ ํŒŒ์ผํ˜•์‹์— ๋งž๋Š” ํ”„๋กœ๊ทธ๋žจ์œผ๋กœ ์ •์ƒ ์ž‘๋™ํ•˜์ง€ ์•Š๋Š” ๊ฒฝ์šฐ ๋‹ค๋ฅธ ์ž๋ฃŒ์™ฟ’ 70% ์ด์ƒ ๋‚ด์šฉ์ด ์ผ์น˜ํ•˜๋Š” ๊ฒฝ์šฐ (์ค‘๋ณต์ž„์„ ํ™•์ธํ•  ์ˆ˜ ์žˆ๋Š” ๊ทผ๊ฑฐ ํ•„์š”ํ•จ) ์ธํ„ฐ๋„ท์˜ ๋‹ค๋ฅธ ์‚ฌ์ดํŠธ, ์—ฐ๊ตฌ๊ธฐ๊ด€, ํ•™๊ป“, ์„œ์  ๋“ฑ์˜ ์ž๋ฃŒ๋ฅผ ๋„์šฉํ•œ ๊ฒฝ์šฐ ์ž๋ฃŒ์˜ ์„ค๋ช…๊ณผ ์‹ค์ œ ์ž๋ฃŒ์˜ ๋‚ด์šฉ์ด ์ผ์น˜ํ•˜์ง€ ์•Š๋Š” ๊ฒฝ์šฐ
    ๋ฌธ์„œ ์ดˆ์•ˆ์„ ์ƒ์„ฑํ•ด์ฃผ๋Š” EasyAI
    ์•ˆ๋…•ํ•˜์„ธ์š”. ํ•ดํ”ผ์บ ํผ์Šค์˜ ๋ฐฉ๋Œ€ํ•œ ์ž๋ฃŒ ์ค‘์—์„œ ์„ ๋ณ„ํ•˜์—ฌ ๋‹น์‹ ๋งŒ์˜ ์ดˆ์•ˆ์„ ๋งŒ๋“ค์–ด์ฃผ๋Š” EasyAI ์ž…๋‹ˆ๋‹ค.
    ์ €๋Š” ์•„๋ž˜์™ฟ’ ๊ฐ™์ด ์ž‘์—…์„ ๋„์™ฟ’๋“œ๋ฆฝ๋‹ˆ๋‹ค.
    - ์ฃผ์ œ๋งŒ ์ž…๋ ฅํ•˜๋ฉด ๋ชฉ์ฐจ๋ถ€ํ„ฐ ๋ณธ๋ๅฉ๋‚ด์šฉ๊นŒ์ง€ ์ž๋™ ์ƒ์„ฑํ•ด ๋“œ๋ฆฝ๋‹ˆ๋‹ค.
    - ์žฅ๋ฌธ์˜ ์ฝ˜ํ…์ธ ๋ฅผ ์‰ฝ๊ณ  ๋น ๋ฅด๊ฒŒ ์ž‘์„ฑํ•ด ๋“œ๋ฆฝ๋‹ˆ๋‹ค.
    - ์Šคํ† ์–ด์—์„œ ๋ฌด๋ฃŒ ์บ์‹œ๋ฅผ ๊ณ„์ •๋ณ„๋กœ 1ํšŒ ๋ฐœ๊ธ‰ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ์ง€๊ธˆ ๋ฐ”๋กœ ์ฒดํ—˜ํ•ด ๋ณด์„ธ์š”!
    ์ด๋Ÿฐ ์ฃผ์ œ๋“ค์„ ์ž…๋ ฅํ•ด ๋ณด์„ธ์š”.
    - ์œ ์•„์—๊ฒŒ ์ ํ•ฉํ•œ ๋ฌธํ•™์ž‘ํ’ˆ์˜ ๊ธฐ์ค€๊ณผ ํŠน์„ฑ
    - ํ•œ๊ตญ์ธ์˜ ๊ฐ€์น˜๊ด€ ์ค‘์—์„œ ์ •์‹ ์  ๊ฐ€์น˜๊ด€์„ ์ด๋ฃจ๋Š” ๊ฒƒ๋“ค์„ ๋ฌธํ™”์  ๋ฌธ๋ฒ•์œผ๋กœ ์ •๋ฆฌํ•˜๊ณ , ํ˜„๋Œ€ํ•œ๊ตญ์‚ฌํšŒ์—์„œ ์ผ์–ด๋‚˜๋Š” ์‚ฌ๊ฑด๊ณผ ์‚ฌ๊ณ ๋ฅผ ๋น„๊ตํ•˜์—ฌ ์ž์‹ ์˜ ์˜๊ฒฌ์œผ๋กœ ๊ธฐ์ˆ ํ•˜์„ธ์š”
    - ์ž‘๋ณ„์ธ์‚ฌ ๋…ํ›„๊ฐ
    ํ•ด์บ  AI ์ฑ—๋ด‡๊ณผ ๋Œ€ํ™”ํ•˜๊ธฐ
    ์ฑ—๋ด‡์œผ๋กœ ๊ฐ„ํŽธํ•˜๊ฒŒ ์ƒ๋‹ดํ•ด๋ณด์„ธ์š”.
    2025๋…„ 07์›” 15์ผ ํ™”์š”์ผ
    AI ์ฑ—๋ด‡
    ์•ˆ๋…•ํ•˜์„ธ์š”. ํ•ดํ”ผ์บ ํผ์Šค AI ์ฑ—๋ด‡์ž…๋‹ˆ๋‹ค. ๋ฌด์—‡์ด ๊ถ๊ธˆํ•˜์‹ ๊ฐ€์š”?
    7:33 ์˜คํ›„